OCKHAM BIOTECH

ockham-biotech-logo

Ockham Biotech is a research company which is focussed on the development of inhaled heparin for the treatment of airway diseases

#Website #More

OCKHAM BIOTECH

Industry:
Biotechnology

Address:
Swanwick, Derbyshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.ockhambiotech.com

Total Employee:
1+

Status:
Active

Contact:
+ 44 (0) 1489 587168

Email Addresses:
[email protected]

Technology used in webpage:
Google Font API LetsEncrypt ASP.NET IIS IIS 8 Parallels Plesk Panel Plesk


Official Site Inspections

http://www.ockhambiotech.com Semrush global rank: 6.14 M Semrush visits lastest month: 1.32 K

  • Host name: web8.srv.host-it.co.uk
  • IP address: 159.253.63.36
  • Location: Mayfair United Kingdom
  • Latitude: 51.5005
  • Longitude: -0.1491
  • Timezone: Europe/London
  • Postal: W1

Loading ...

More informations about "Ockham Biotech"

Ockham Biotech - Welcome

The compelling science and a remarkable opportunity Welcome to Ockham Biotech. We are a research company focussed on the development of inhaled heparin for the treatment of โ€ฆSee details»

Ockham Biotech - Crunchbase Company Profile & Funding

Ockham Biotech is a research company which is focussed on the development of inhaled heparin for the treatment of airway diseasesSee details»

Ockham Biotech - Board of Directors

The Ockham Biotech Board of Directors Andy Short, Executive Chairman. Andy Short is the Executive Chairman, co-founding Ockham Biotech Limited in 2006 and commercialising the โ€ฆSee details»

Ockham Biotech - VentureRadar

Private Company "Ockham Biotech Ltd. is a research company which is focussed on the development of inhaled heparin for the treatment of obstructive airway diseases, including โ€ฆSee details»

OCKHAM BIOTECH LIMITED overview - Find and update company โ€ฆ

OCKHAM BIOTECH LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business โ€ฆSee details»

Ockham Biotech - Company Profile - Tracxn

Feb 27, 2025 Ockham Biotech - Developer of therapeutics for the treatment of obstructive diseases.See details»

OCKHAM BIOTECH LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for OCKHAM BIOTECH LIMITED of FAREHAM. Get the latest business insights from Dun & Bradstreet.See details»

Ockham Biotech - About Ockham

Founded in 2006 by Professor Janis Kay Shute and Andy Short, Ockham Biotech is a medical research company. We are currently developing a novel form of heparin codenamed OCK4, โ€ฆSee details»

Ockham Biotech - Craft

See insights on Ockham Biotech including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Ockham Biotech Ltd.:Company Profile & Technical โ€ฆ

Discovery Company profile page for Ockham Biotech Ltd. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

Ockham Biotech - Overview, News & Competitors | ZoomInfo.com

View Ockham Biotech (www.ockhambiotech.com) location in Hampshire, United Kingdom , revenue, industry and description. Find related and similar companies as well as employees โ€ฆSee details»

Ockham Biotech - VentureRadar

VentureRadar Research / Company Website Dansk Biotek DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for โ€ฆSee details»

Ockham Biotech CEO and key executive team - Craft.co

Ockham Biotech's Executive Chairman. is Andy Short. Ockham Biotech's key executives include Andy Short and 4 others.See details»

Ockham Biotech Ltd.: Drug pipelines, Patents, Clinical trials - Synapse

Nov 21, 2023 Explore Ockham Biotech Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Immune System Diseases, Hemic and Lymphatic Diseases ...See details»

Ockham Biotech - WHY INVEST IN OCKHAM BIOTECH LIMITED?

Ockham Biotech Ltd is currently seeking partners for the commercialisation of inhaled heparin in COPD, bronchiectasis, asthma, cystic fibrosis and other diseases characterised by airway โ€ฆSee details»

Ockham Biotech Ltd. (Ockham Biotech Ltd.) - ่ฏ็‰ฉ็ฎก็บฟ_ไธ“ๅˆฉ_ไธดๅบŠ โ€ฆ

ไบ†่งฃOckham Biotech Ltd. (Ockham Biotech Ltd.)ๅ…ฌๅธ็š„่ฏ็‰ฉ็ฎก็บฟ๏ผŒๆฒป็–—้ข†ๅŸŸ๏ผŒๆŠ€ๆœฏๅนณๅฐ๏ผŒไปฅๅŠๅฎƒ็š„๏ผŒ็–พ็—…้ข†ๅŸŸ:่ก€ๆถฒๅŠๆท‹ๅทด็ณป็ปŸ็–พ็—…๏ผŒๅ…็–ซ็ณป็ปŸ็–พ็—…๏ผŒๆŠ€ๆœฏๅนณๅฐ:ๅŒ–ๅญฆ่ฏ๏ผŒ่ฏ็‰ฉ:่‚็ด ้’™ใ€‚See details»

Ockham Biotech | VentureRadar

Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โ€ฆSee details»

Ockham Biotech - EUROPEAN PATENT

This major collaborative funding arrangement will enable Ockham Biotech and Life Arc to undertake research into inhaled heparin derivatives in cystic fibrosis and non-CF โ€ฆSee details»

Simplification for success: Rewiring the biopharma operating model

Mar 21, 2025 Less than a third of the 50 leaders we surveyed believe their organization currently possesses the talent and capabilities required to support future product portfolios, including โ€ฆSee details»

Ockham Biotech - Clinical Trials

Phase IIa trials in patients with CF and NCFBE Ockham, together with the support of Life Arc (see News are currently developing a proprietary formulation of heparin (OCK4), in a bespoke hand โ€ฆSee details»